RNAi: A REVOLUTION IN BIOLOGY BUILT ON NOBEL PRIZE-WINNING RESEARCH
RNA interference (RNAi) is a breakthrough in understanding how genes are regulated in cells. It also represents a completely new approach to drug discovery and development. The 2006 Nobel Prize for Physiology or Medicine, awarded to Craig Mello and Andrew Fire, recognised the importance of RNAi as a major scientific discovery.
JOIN OUR TEAM
As we pursue our goal of becoming a commercial organisation that can independently deliver medicines to patients, we are seeking individuals with diverse skills, experiences, and backgrounds to help us build a world-class team. We are based in Cambridge, USA, with offices in Zug, Switzerland, and Maidenhead, UK, but we are also hiring throughout Europe.
CONTACT US
KUÌåÓý UK Ltd.
Braywick Gate, Braywick Road, Maidenhead, Berkshire SL6 1DA
For medical information, clinical trial questions or to report an adverse event or product complaint:
Toll: +44 1628878592
Toll-free: 08001412569 (also hidden caller ID)
Patient Organization Support
View lists of the past UK patient organizations that KUÌåÓý supported in:
Joint Working Agreements
View the Executive Summaries for Joint Working Agreements with KUÌåÓý UK below:
Live Joint Workings
- National Amyloidosis Centre - hATTR amyloidosis Genetic Counselling and Testing
- National Hospital for Neurology and Neurosurgery and National Amyloidosis Centre
Completed Joint Workings
- National Amyloidosis Centre - hATTR amyloidosis Therapeutic Review - Executive Summary
- National Amyloidosis Centre - hATTR amyloidosis Therapeutic Review - Joint Working Outcomes Summary
- University Hospital Birmingham- Executive Summary
- University Hospital Birmingham- Joint Working Outcomes Summary
UK Disclosure Reports
UK Disclosure Reports are available on the .
The UK Transparency Reporting Methodological Note can be viewed here.
Product Information
For information on KUÌåÓý products, please see:
Reporting of Side Effects
Reporting of side effects: If you have any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the . By reporting side effects, you can help provide more information on the safety of this medicine.
KUÌåÓý UK Ltd.
Date of prep: November 2024
CORP-UK-00048
The following content may not be associated with KUÌåÓý Pharmaceuticals.
Links to all outside sites are provided as a reference for our visitors.
KUÌåÓý Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by KUÌåÓý Pharmaceuticals.
Proceed to SiteYou are being re-directed to an external website unconnected to KUÌåÓý UK Ltd and the KUÌåÓý group. You are solely responsible for your interactions with that website.
Links to all external sites are provided as a reference for our visitors.
KUÌåÓý UK Ltd and the KUÌåÓý group do not endorse and are not responsible for the content on websites that are not owned and operated by them.
Proceed to Site